These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31024121)

  • 1. The unintended consequences of argument dilution in direct-to-consumer drug advertisements.
    Sivanathan N; Kakkar H
    Nat Hum Behav; 2017 Nov; 1(11):797-802. PubMed ID: 31024121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Individual- and Ad-Level Predictors of Perceptions of Serious and Actionable Risks in Direct-to-Consumer Prescription Drug TV Advertising.
    Aikin KJ; Boudewyns V; Betts KR; Southwell BG; Williams P
    J Health Commun; 2019; 24(5):536-546. PubMed ID: 31253071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Animated Spokes-Characters in Print Direct-to-Consumer Prescription Drug Advertising: An Elaboration Likelihood Model Approach.
    Bhutada NS; Rollins BL; Perri M
    Health Commun; 2017 Apr; 32(4):391-400. PubMed ID: 27315337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of comparative claims in prescription drug direct-to-consumer advertising on consumer perceptions and recall.
    O'Donoghue AC; Williams PA; Sullivan HW; Boudewyns V; Squire C; Willoughby JF
    Soc Sci Med; 2014 Nov; 120():1-11. PubMed ID: 25194471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay.
    Aikin KJ; Southwell BG; Paquin RS; Rupert DJ; O'Donoghue AC; Betts KR; Lee PK
    Res Social Adm Pharm; 2017; 13(2):378-388. PubMed ID: 27178746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fair Balance and Adequate Provision in Direct-to-Consumer Prescription Drug Online Banner Advertisements: A Content Analysis.
    Adams C
    J Med Internet Res; 2016 Feb; 18(2):e33. PubMed ID: 26892749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riskier than we think? The relationship between risk statement completeness and perceptions of direct to consumer advertised prescription drugs.
    Davis JJ
    J Health Commun; 2000; 5(4):349-69. PubMed ID: 11191018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of imagination in consumers' processing of visual metaphors in prescription drug advertising.
    Foreman JR; Hsieh MH; Grover A
    Health Mark Q; 2019; 36(3):169-185. PubMed ID: 31180277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do dissonant ad visuals cause consumers to discount prescription drug side effects?
    Hagenbuch D
    Health Mark Q; 2019; 36(4):337-353. PubMed ID: 31646956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.
    Klara K; Kim J; Ross JS
    J Gen Intern Med; 2018 May; 33(5):651-658. PubMed ID: 29484575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.
    Kim H
    Int J Health Policy Manag; 2015 Aug; 4(12):813-21. PubMed ID: 26673465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asking a doctor versus referring to the Internet: A comparison study on consumers' reactions to DTC (direct-to-consumer) prescription drug advertising.
    Jiang P
    Health Mark Q; 2018; 35(3):209-226. PubMed ID: 30551729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'At-risk' individuals' responses to direct to consumer advertising of prescription drugs: a nationally representative cross-sectional study.
    Khalil Zadeh N; Robertson K; Green JA
    BMJ Open; 2017 Dec; 7(12):e017865. PubMed ID: 29217723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study.
    Sullivan HW; O'Donoghue AC; Aikin KJ; Chowdhury D; Moultrie RR; Rupert DJ
    Patient Educ Couns; 2016 May; 99(5):790-9. PubMed ID: 26749356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDA direct-to-consumer advertising for prescription drugs: what are consumer preferences and response tendencies?
    Khanfar N; Loudon D; Sircar-Ramsewak F
    Health Mark Q; 2007; 24(1-2):77-91. PubMed ID: 19042521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-specific direct-to-consumer advertising for reminding consumers to take medications.
    Bhutada NS; Rollins BL
    J Am Pharm Assoc (2003); 2015; 55(4):434-7. PubMed ID: 26161486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease Information in Direct-to-Consumer Prescription Drug Print Ads.
    Aikin KJ; Sullivan HW; Betts KR
    J Health Commun; 2016; 21(2):228-39. PubMed ID: 26717304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.
    Williams PA; O'Donoghue AC; Sullivan HW; Willoughby JF; Squire C; Parvanta S; Betts KR
    Patient Educ Couns; 2016 Apr; 99(4):583-590. PubMed ID: 26589655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct-to-consumer promotion of prescription drugs. Economic implications for patients, payers and providers.
    Findlay SD
    Pharmacoeconomics; 2001; 19(2):109-19. PubMed ID: 11284378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of involvement and ad type on attitudes toward direct-to-consumer advertising of prescription drugs.
    Limbu Y; Torres IM
    J Health Hum Serv Adm; 2009; 32(1):107-38. PubMed ID: 19558035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.